Skip to content

Comparison of Intra Muscular Oxytocin 10 Units Vs Oxytocin 5U plus Ergometrine 0.2mg Vs Carbetocin 100mcg in reduction of Postpartum Blood lossâ?? A Randomized Controlled Trial â??

Intra Muscular Oxytocin 10 Units Vs Oxytocin 5U plus Ergometrine 0.2mg Vs Carbetocin 100mcg in reduction of Post-Partum Blood lossâ?? A Randomized Controlled Trial â??

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053086
Enrollment
132
Registered
2023-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Arm 1- Inj Oxytocin 10units Arm 2 - Inj Oxytocin 10units plus Inj Ergometrine 0.2mg Arm 3 - Inj Carbetocin 100mcg: Arm 1- Inj Oxytocin 10units given through intramuscular route once Arm

Sponsors

Dr TSaieswari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Singleton live gestation 2 Gestational age between 37 0/7 to 41 6/7 3 After obtaining informed written consent 4 Women admitting in labour (

Exclusion criteria

Exclusion criteria: 1 Hypertensive disorders of pregnancy 2 Known medical disorders 3 Antepartum haemorrhage 4 Known epileptic patients 5 Known coagulopathies 6 Known hemoglobinopathies • Placental abnormalities • Known contraindications to study drugs • Women who are not willing to consent for the study

Design outcomes

Primary

MeasureTime frame
To determine the effectiveness uterotonic drug (oxytocin or carbetocin or oxytocin + ergometrine) which helps in reducing the post partum blood lossTimepoint: depends on the baby delivery time

Secondary

MeasureTime frame
â?¢ To estimate the proportion of women receiving extra uterotonic drugs â?¢ Women requiring transfusion of blood or blood products â?¢ Use of other measures to treat postpartum hemorrhage like examining under anaesthetic care or uterine compression or intra uterine balloon tamponade. Timepoint: to estimate within 24 hours

Countries

India

Contacts

Public ContactSaieswari Teegela

JNMC, KLEH

drmbbellad@hotmail.com9448124893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026